The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| INFU | +35.15% | -24.51% | -5.46% | +85% |
| S&P | +12.65% | +91.73% | +13.89% | +436% |
InfuSystem Holdings, Inc. engages in the provision of healthcare services. It operates through the Integrated Therapy Services and Durable Medical Equipment segments. The Integrated Therapy Services segment focuses on providing electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics, and hospital outpatient oncology clinics. The Durable Medical Equipment segment is involved in the rental, sale or leasing of pole-mounted and ambulatory infusion pumps to oncology practices, hospitals, and other clinical settings. The company was founded in August 2005 and headquartered in Rochester Hills, MI.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $36.49M | 3.3% |
| Gross Profit | $20.31M | 9.8% |
| Gross Margin | 55.65% | 3.3% |
| Market Cap | $211.61M | 48.2% |
| Market Cap / Employee | $0.41M | 0.0% |
| Employees | 514 | -0.4% |
| Net Income | $2.26M | 25.0% |
| EBITDA | $7.10M | 10.7% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $0.96M | 151.3% |
| Accounts Receivable | $24.31M | 6.8% |
| Inventory | 5.6 | -16.6% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $24.69M | -24.8% |
| Short Term Debt | $0.00M | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.41% | 4.0% |
| Return On Invested Capital | 5.77% | 0.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $8.41M | -14.1% |
| Operating Free Cash Flow | $8.49M | -13.7% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 78.97 | 36.65 | 26.31 | 39.60 | -60.16% |
| Price to Book | 3.23 | 1.99 | 2.37 | 3.88 | 45.33% |
| Price to Sales | 1.36 | 0.83 | 0.94 | 1.54 | 40.82% |
| Price to Tangible Book Value | 3.98 | 2.42 | 2.89 | 4.85 | 45.30% |
| Price to Free Cash Flow TTM | 9.48 | 5.46 | 5.12 | 8.95 | -1.41% |
| Enterprise Value to EBITDA | 35.29 | 36.90 | 22.64 | 33.93 | 22.50% |
| Free Cash Flow Yield | 10.5% | 18.3% | 19.5% | 11.2% | 1.43% |
| Return on Equity | 4.3% | 5.9% | 9.4% | 10.0% | 258.81% |
| Total Debt | $29.90M | $33.17M | $30.45M | $24.69M | -24.84% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
